New once-daily formula combines lutein, zeaxanthin, zinc, beta-carotene, lycopene, rose hips, vitamin A, taurine, grape seed extract and bilberry extract, with an ingredient-by-ingredient research overview
AURORA, Colo., Sept. 20, 2026 — Zenith Labs today announced the U.S. launch of Vision 20, its ten-ingredient daily capsule supplement formulated to support vision and eye wellness in adults. The once-daily formula combines carotenoid compounds, an essential mineral, antioxidant extracts, an amino acid and a fat-soluble vitamin in a capsule designed to support normal macular function, normal antioxidant protection of eye tissue and normal visual performance. It is designed for adults who want a daily vision wellness supplement that fits into an established routine of balanced nutrition, physical activity and regular eye care.
The formula contains lutein, zeaxanthin, zinc, beta-carotene, lycopene, rose hips extract, vitamin A (retinyl palmitate), taurine, grape seed extract and bilberry extract. The recommended serving is one capsule daily. All ingredient names and amounts are disclosed on the Supplement Facts label at bestvisionsupport.com; consumers are encouraged to review the full label before use. Vision 20 is manufactured in a facility that is regularly audited by the FDA for safety and purity standards. The formula is gluten-free and non-GMO.
Alongside the launch, Zenith Labs is publishing an ingredient overview that summarizes published research on each component. The overview also explains where that research stops and what it does not establish about the finished product.
“Vision wellness supplements are often sold on bold promises built from loosely connected studies,” said Dr. Ryan Shelton, Medical Research Director at Zenith Labs. “We took the opposite approach. Vision 20 is a straightforward daily formula, and we’re telling consumers exactly what’s in it, what the science on each ingredient actually shows, and where the evidence is still limited.”
A Ten-Ingredient Formula for Daily Vision and Eye Wellness
Vision 20’s formula draws from four ingredient categories, each associated with different aspects of normal eye function:
- Macular carotenoids: Lutein and zeaxanthin are the principal dietary carotenoids that concentrate in the macula, where they function as blue-light filters and antioxidants protecting photoreceptor cells from oxidative stress associated with light exposure.
- Carotenoid and absorption support: Zinc, beta-carotene and lycopene contribute to normal carotenoid absorption and antioxidant protection of eye tissue — zinc is recognized for its role in transporting vitamin A to the retina and activating the function of other eye health nutrients.
- Antioxidant botanical extracts: Rose hips extract, grape seed extract and bilberry extract contribute polyphenolic and anthocyanin compounds studied in the context of antioxidant protection of retinal tissue and normal ocular microcirculation.
- Supporting nutrients: Vitamin A (retinyl palmitate) and taurine are established nutritional compounds with recognized roles in normal visual function and normal retinal cell health.
The combination reflects the company’s view that vision wellness involves multiple interconnected systems — including macular pigment density, retinal antioxidant protection, normal ocular blood supply and normal photoreceptor function — rather than a single pathway. Zenith Labs emphasizes that this is a formulation rationale, not a clinical finding. The finished product has not been evaluated as a complete formula in published clinical trials.
Lutein and Zeaxanthin: Macular Carotenoids With an Established Research Base
Lutein and zeaxanthin are dietary carotenoids that concentrate preferentially in the macula — the central region of the retina responsible for sharp, detailed vision. They function as blue-light filters and antioxidants, protecting photoreceptor cells from oxidative stress.
The Age-Related Eye Disease Study 2 (AREDS-2), a large-scale randomized controlled trial by the National Eye Institute in approximately 4,000 adults aged 50–85 with intermediate or advanced age-related macular degeneration (AMD), found that a formulation containing lutein and zeaxanthin reduced the risk of progression to advanced AMD compared with the original AREDS formulation. These findings apply specifically to that clinical population at those specific doses, and do not establish outcomes for healthy adults or for the finished Vision 20 formula. Consumers are directed to the product label for the specific doses of lutein and zeaxanthin in Vision 20 and should consult a qualified eye care professional for guidance specific to their eye health.
Zinc: An Essential Mineral Supporting Normal Retinal Function
Zinc is an essential trace mineral with a recognized role in normal retinal function, including the transport of vitamin A from the liver to the retina and the activation of rhodopsin — the light-sensitive pigment in rod cells. Zinc was a component of the AREDS and AREDS-2 study formulations, studied in adults with diagnosed AMD at specific doses over defined study periods.
These findings apply to specific doses in a defined clinical population and do not establish outcomes from the finished Vision 20 formula. Adults already consuming zinc from a multivitamin should consider their combined intake; the tolerable upper intake level for adults is 40 mg per day from all sources. Its inclusion reflects zinc’s established nutritional role in normal retinal function, not a product-specific clinical claim.
Beta-Carotene: A Provitamin A Carotenoid With Antioxidant Properties
Beta-carotene is a dietary carotenoid found in red, orange and yellow vegetables and a recognized provitamin A compound — meaning the body converts it to vitamin A as needed. Research has examined beta-carotene in the context of antioxidant protection of eye tissue and normal photoreceptor function. The AREDS study included beta-carotene in its original formulation, though AREDS-2 replaced it with lutein and zeaxanthin in the updated formula.
Consumers who smoke or have a history of smoking should consult a qualified healthcare professional before using beta-carotene supplements, as some research has associated high-dose beta-carotene supplementation in smokers with increased risk of lung conditions. Its inclusion in Vision 20 reflects its recognized antioxidant research profile in the context of eye tissue protection, not a product-specific clinical claim. Consumers are directed to the product label for the specific dose.
Lycopene: An Antioxidant Carotenoid With a Prostate and Eye Wellness Research Profile
Lycopene is a carotenoid pigment found in tomatoes and other red-pigmented produce, studied for its antioxidant properties and relationship to normal cellular health. Research on lycopene in eye wellness contexts has examined its antioxidant activity in retinal tissue and its association with normal eye health markers in population studies.
These associations are observational in nature and do not establish causal relationships between lycopene supplementation and eye outcomes. Its inclusion reflects the recognized antioxidant research profile of lycopene as a dietary carotenoid, not a product-specific clinical claim.
Rose Hips Extract: Research on Antioxidant Activity and Eye Tissue Support
Rose hips are the fruit of rose bushes (Rosa spp.) and are recognized as a concentrated source of vitamin C, flavonoids and other antioxidant compounds. Rose hips extract has been studied in the context of antioxidant activity and normal inflammatory balance across a range of tissue types.
Research has examined rose hips extract’s antioxidant compounds in the context of normal cellular protection. Human clinical evidence specifically for vision outcomes is limited. Its inclusion reflects the recognized antioxidant research profile of rose hips extract as a complementary ingredient in the formula’s broader antioxidant support rationale, not a product-specific clinical claim.
Vitamin A (Retinyl Palmitate): An Essential Nutrient for Normal Visual Function
Vitamin A (retinyl palmitate) is an essential fat-soluble micronutrient and precursor to retinal — the light-sensitive compound in rhodopsin responsible for normal low-light and night vision. Vitamin A deficiency is recognized by the World Health Organization as a leading cause of preventable blindness globally.
Its inclusion reflects its established nutritional role in normal visual function rather than a product-specific clinical claim. Adults already consuming adequate vitamin A through diet or a multivitamin should consider their combined intake. The tolerable upper intake level for preformed vitamin A is 3,000 mcg RAE per day; excessive intake carries recognized toxicity risks. Consumers are directed to the product label for the specific vitamin A amount in Vision 20.
Taurine: An Amino Acid With a Recognized Role in Normal Retinal Function
Taurine is a naturally occurring amino acid found in high concentrations in retinal tissue and plays a recognized role in normal retinal cell function. Research has examined the relationship between taurine levels and normal photoreceptor health, with studies noting that taurine deficiency in animal models has been associated with retinal degeneration.
Human clinical evidence on taurine supplementation specifically for vision outcomes is more limited. Its inclusion reflects the recognized nutritional role of taurine in normal retinal cell function, not a product-specific clinical claim. Consumers are directed to the product label for the specific taurine dose in Vision 20.
Grape Seed Extract: Research on Antioxidant Activity and Ocular Tissue Protection
Grape seed extract (Vitis vinifera) is standardized to contain oligomeric proanthocyanidins (OPCs) — polyphenolic compounds with antioxidant properties. Research has examined OPCs in the context of antioxidant protection of lens cells and normal ocular vascular function, with laboratory studies observing antioxidant activity in eye tissue models.
A systematic review noted associations between grape seed OPC supplementation and improvements in antioxidant markers in adult participants. These studies had important limits and their findings describe how OPCs interact with antioxidant markers, not outcomes from the finished Vision 20 formula. Its inclusion reflects the recognized antioxidant research profile of grape seed OPCs, not a product-specific clinical claim.
Bilberry Extract: Research on Retinal Antioxidant Activity and Ocular Circulation
Bilberry (Vaccinium myrtillus) extract is rich in anthocyanins — polyphenolic compounds studied for their antioxidant properties and relationship to normal retinal tissue protection and normal ocular microcirculation. Bilberry extract has a recognized place in European phytomedicine for eye health.
A systematic review of available clinical trials noted inconsistent findings across studies, citing small sample sizes, variable preparations and inconsistent outcome measures as limiting factors. Human clinical evidence specifically for vision outcomes is more limited than the traditional use history might suggest. Its inclusion reflects the recognized antioxidant research profile of bilberry anthocyanins, not a product-specific clinical claim.
What Ingredient Research Does and Does Not Show
Vision 20’s research overview separates three questions: what each ingredient is, what researchers have studied about it, and what has been demonstrated about the finished formula. Those questions have different answers.
The AREDS-2 findings cited for lutein, zeaxanthin and zinc are the strongest evidence in this formula’s research base. They apply specifically to adults with intermediate to advanced AMD, at specific doses, over a specific study period. They do not establish that these nutrients prevent AMD in healthy adults or that Vision 20 produces the same outcomes as the AREDS-2 study. The doses of the AREDS-2 nutrients in Vision 20 may differ from those used in that study.
The remaining ingredients have individual research profiles of varying strength. Their findings are from studies of isolated ingredients in specific conditions and do not establish outcomes from the finished Vision 20 formula.
“We think consumers respond better to honesty than hype,” said Dr. Ryan Shelton. “Every ingredient in Vision 20 has a recognized nutritional role or an active research profile. What we won’t do is stretch a study beyond what it found.”
Safety and Suitability
Vision 20 is intended for healthy adults. Individuals taking prescription medication — particularly anticoagulants, antiplatelet drugs or blood pressure medication — should consult a qualified healthcare professional before use. High-dose vitamin E and ginkgo biloba, which are not in this formula, are commonly associated with blood-thinning interactions; consumers should review the full ingredient label.
Individuals who smoke or have a history of smoking should consult a qualified healthcare professional before using this or any supplement containing beta-carotene. Adults already consuming a multivitamin should consider their combined intake of vitamins A, zinc and other overlapping nutrients from all sources.
Vision 20 is a dietary supplement and is not a substitute for professional eye examinations, prescription treatment, corrective lenses or other recommended eye care. Individuals with AMD or other diagnosed eye conditions should consult a qualified ophthalmologist or optometrist before use and should not discontinue prescribed treatment in favour of dietary supplementation.
The physical label and Supplement Facts panel at bestvisionsupport.com are the definitive source for all ingredient names, amounts, directions and warnings.
Product Format and Availability
Vision 20 is available now to consumers across the United States through the official Zenith Labs website at bestvisionsupport.com. The recommended serving is one capsule daily. Manufactured in a facility regularly audited by the FDA; gluten-free and non-GMO. All orders are backed by a 180-day money-back guarantee.
Under U.S. federal law, dietary supplements are not subject to pre-market FDA approval. FDA facility audits cover manufacturing standards and quality controls and do not constitute endorsement of the product or its claims.
About Zenith Labs and Vision 20
Zenith Labs was founded with the conviction that evidence-informed wellness supplements should be built around transparency — disclosing every ingredient, explaining the research behind each one accurately and acknowledging the limits of that research with equal clarity. The company’s mission is to develop formulas that address specific physiological systems with credible, well-sourced ingredients, manufactured to the highest quality standards. Every Zenith Labs product is developed in collaboration with healthcare practitioners and produced in a facility that undergoes regular FDA auditing.
Vision 20 holds itself to three standards: complete ingredient and dose disclosure on the Supplement Facts label, manufacturing in a facility regularly audited by the FDA, and accurate representation of the science behind each component — including its limits. Vision 20’s formula combines lutein, zeaxanthin, zinc, beta-carotene, lycopene, rose hips extract, vitamin A, taurine, grape seed extract and bilberry extract in a once-daily capsule. Gluten-free and non-GMO. More information is available at bestvisionsupport.com.
References
- Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the AREDS2 randomized clinical trial. JAMA. 2013;309(19):2005–2015.
- National Institutes of Health, Office of Dietary Supplements. Zinc: Fact Sheet for Health Professionals.
- National Institutes of Health, Office of Dietary Supplements. Vitamin A and Carotenoids: Fact Sheet for Health Professionals.
- Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. Journal of the National Cancer Institute. 1999;91(4):317–331.
- Yeum KJ, Russell RM. Carotenoid bioavailability and bioconversion. Annual Review of Nutrition. 2002;22:483–504.
- Hayes KC, Carey RE, Schmidt SY. Retinal degeneration associated with taurine deficiency in the cat. Science. 1975;188(4191):949–951.
- Bagchi D, Bagchi M, Stohs SJ, et al. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology. 2000;148(2–3):187–197.
- Canter PH, Ernst E. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision — a systematic review of placebo-controlled trials. Survey of Ophthalmology. 2004;49(1):38–50.
- National Institutes of Health, Office of Dietary Supplements. Beta-Carotene: Fact Sheet for Health Professionals.
Media Contact
Dr. Ryan Shelton, Medical Research Director
Zenith Labs / Vision 20
19655 E 35th Dr, Suite 100, Aurora, CO 80011, USA
Email: Support@ZenithLabs.com
Phone: +1 (800) 928-1184
Website: bestvisionsupport.com
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Research cited in this release pertains to individual ingredients studied in isolation; it does not represent clinical evaluation of the Vision 20 formula as a finished product, nor does it constitute endorsement by the referenced researchers, journals or institutions. Vision 20 is not a substitute for professional eye examination, prescription treatment or other recommended eye care.
The post Vision 20 Reviews: Zenith Labs Launches Ten-Ingredient Daily Capsule Supplement for Vision and Eye Wellness in the U.S. appeared first on 24 Health Times.
